Power3 Medical Products, Inc. (PWRM.OB) recently announced that it delivered four poster presentations at the 2010 International Conference on Alzheimer’s Disease (ICAD) in Honolulu, Hawaii. These presentations discussed NuroPro®, Power3’s diagnostic test, and focused on Power3’s Alzheimer’s disease blood serum biomarkers, test and clinical validation trials.

Oracle Corp. (NASDAQ:ORCL) announced today fiscal 2011 Q1 GAAP total revenues were up 48% to $7.5 billion, while non-GAAP total revenues were up 50% to $7.6 billion. GAAP new software license revenues were up 25% to $1.3 billion. Both the GAAP and non-GAAP software license updates and product support revenues were up 11% to $3.5 billion.